Highlights Mayne Pharma Group Limited

Equities

MYX

AU000000MYX0

Delayed Australian S.E. Other stock markets 23:17:14 2024-05-08 EDT			5-day change	1st Jan Change
7.14 ^AUD	0.00%		+1.85%	+16.10%

02-26	Mayne Pharma Group Swings to Loss in Fiscal H1 Despite Revenue Growth; Shares Jump 15%	MT
02-25	Transcript : Mayne Pharma Group Limited, H1 2024 Earnings Call, Feb 26, 2024

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Mayne Pharma Group Swings to Loss in Fiscal H1 Despite Revenue Growth; Shares Jump 15%	02-25	MT
Mayne Pharma Group Limited Reports Earnings Results for the Half Year Ended December 31, 2023	02-25	CI
Mithra Pharmaceuticals Exits Stake in Mayne Pharma	02-16	MT
An undisclosed buyer acquired a 5.06% stake in Mayne Pharma Group Limited from Mithra Pharmaceuticals SA for AUD 21 million	02-14	CI
Mayne Pharma Gets Additional US Patent for Contraceptive	11-06	MT
Mayne Pharma Gets Go-Ahead for Resignation of EY as Auditor	11-03	MT
Mayne Pharma Acquires Dermatological Medication	23-09-26	MT
Mayne Pharma Group Limited completed the acquisition of Assets Related To RHOFADE® (Oxymetazoline Hydrochloride) Cream 1% from EPI Health, LLC.	23-09-24	CI
Mayne Pharma Group Limited agreed to acquire Assets Related To RHOFADE® (Oxymetazoline Hydrochloride) Cream 1% from EPI Health, LLC for $8 million.	23-09-06	CI
Mayne Pharma Group Purchasing Global Rights to Topical Treatment RHOFADE	23-09-04	MT
Tranche Update on Mayne Pharma Group Limited's Equity Buyback Plan announced on May 10, 2023.	23-08-30	CI
Mayne Pharma Group Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-30	CI
Lupin Gets US FDA Nod for Doxycycline Hyclate Delayed-Release Tablets	23-08-14	MT
Mithra Pharmaceuticals Cuts Mayne Pharma Group Stake to 4.96%	23-06-19	MT
An unknown buyer acquired a 4.97% stake in Mayne Pharma Group Limited from Estetra Srl for AUD 16 million.	23-06-15	CI
Mayne Pharma Group Limited announces an Equity Buyback for 8,507,428 shares, representing 10% of its issued share capital.	23-05-09	CI
Mayne Pharma Group Limited authorizes a Buyback Plan.	23-05-09	CI
Mayne Pharma Sells US Retail Generics Portfolio for AU$134 Million; Shares Climb 5%	23-04-10	MT
Dr Reddy Acquires Mayne Pharma's US Generic Prescription Drug Portfolio	23-04-07	MT
Dr. Reddy's Laboratories SA completed the acquisition of US retail generics portfolio of Mayne Pharma Group Limited.	23-04-05	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Mayne Pharma Group Limited

Equities

MYX

AU000000MYX0

Highlights

Filters